Dr. Philipovskiy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
805 Currency circle
Lake Mary, FL 32746Phone+1 407-804-6100- Is this information wrong?
Education & Training
- Westchester Medical CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
- Westchester Medical CenterResidency, Internal Medicine, 2010 - 2013
- Odessa Medical UniversityClass of 1996
Certifications & Licensure
- FL State Medical License 2022 - 2026
- TX State Medical License 2016 - 2024
- NY State Medical License 2015 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Adherence of Hispanic / Latina Breast Cancer - Patients to Adjuvant Aromatase Inhibitors Start of enrollment: 2017 Apr 26
- Predicting Response of Metastatic Triple Negative Breast Cancer to Immunotherapy Based on Patients Cytokine Profile Start of enrollment: 2019 Jul 02
Publications & Presentations
PubMed
- 1 citationsRecently approved treatment options for patients with metastatic triple-negative and HER2-neu-positive breast cancer.Sayed Reshad Ghafouri, Suvarna Guvvala, Catherine Jones, Alexander Philipovskiy> ;Journal of Investigative Medicine. 2022 Aug 1
- 2 citationsThe impact of minimally invasive surgery and frailty on post-hepatectomy outcomes.Felipe B Maegawa, Maria Ahmad, Katherine Aguirre, Sherif Elhanafi, Shintaro Chiba, Alexander Philipovskiy, Alan H Tyroch, Ioannis T Konstantinidis> ;HPB. 2022 Sep 1
- 1 citationsPancreatic Neuroendocrine Tumors: The Effect of Facility Type on Patient Survival.Sara Lee, Felipe B Maegawa, Sharon Joseph, Luis A Alvarado, Antonio Mendoza-Ladd, Sherif Elhanafi, Alexander Philipovskiy, Alan H Tyroch, Ioannis T Konstantinidis> ;Pancreas. 2022 Mar 1
- Join now to see all
Journal Articles
- Incorporating Bortezomib in the Management of Plasmablastic Lymphoma.Umeanaeto O, Gamboa J, Diaz J, Hakim MN, Corral J, Philipovskiy A, Gaur S, Anticancer Research, 9/1/2019
- Efficacy of Neoadjuvant Versus Adjuvant Chemotherapy in Hispanic/Latino (H/L) Women With Local or Locally Advanced Triple-negative Breast Cancer (TNBC).Philipovskiy A, Corral J, Dwivedi KA, Heydarian R, Gaur S., In vivo, 6/1/2019
Press Mentions
- TTUHSC El Paso Assistant Professor Elected Regional Chair-Elect for International Research OrganizationAugust 12th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: